Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting125%
terminated125%
completed250%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation

NCT06892457
completed

Alterations in the Brain's Connectome After Severe Traumatic Brain Injury

NCT02424656
terminatednot_applicable

Innovative Biomarkers in de Novo Parkinson's Disease

NCT03940677
completednot_applicable

Characterization of Altered Waking States of Consciousness in Healthy Humans

NCT03853577

Clinical Trials (4)

Showing 4 of 4 trials
NCT06892457

PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation

Recruiting
NCT02424656

Alterations in the Brain's Connectome After Severe Traumatic Brain Injury

Completed
NCT03940677Not Applicable

Innovative Biomarkers in de Novo Parkinson's Disease

Terminated
NCT03853577Not Applicable

Characterization of Altered Waking States of Consciousness in Healthy Humans

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4